Summary
The experimental antitumor activity of a series of new nitrosoureas is described in which the chloroethylnitrosocarbamoyl (CNC) group is attached to different carrier molecules: amino acids and oligopeptides.
Of a group of 10 CNC-amino acid amide derivatives the majority displayed high therapeutic activity in L 5222 leukemia. Some compounds, especialy the proline and sarcosine derivatives, showed favorable therapeutic ratios; 12 CNC-oligopeptides displayed a more or less pronounced therapeutic activity in L 1210 leukemia. Compounds bearing a free carboxy group were less active than the corresponding unsubstituted or N-methyl substituted amides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cleare MJ (1984) Further objectives in the development of platinum drugs. In: Harrap KR, Davis W, Calvert AH (eds) Cancer chemotherapy and selective drug development. Nijhoff, Boston pp 357–362
Ehresmann K (1985) Synthese und Eigenschaften cytostatisch wirksamer 2-Chloroethylnitrosoharnstoffe. Inaug Diss, University Heidelberg
Ehresmann K, Zelezny O, Eisenbrand G (1984) Syntheses of potentially antineoplastic amides and esters of N-[N′(2-chloroethyl)-N′-nitrosocarbamoyl] amino acids, II. Arch Pharm 317:481–487
Eisenbrand G, Habs M, Zeller WJ, Fiebig H, Berger M, Zelezny O, Schmähl D (1981) New Nitrosoureas — therapeutic and long-term toxic effects of selected compounds in comparison to established drugs. In: Serrou B, Schein PS, Imbach JL (eds) Nitrosoureas in cancer treatment. Elsevier, Amsterdam, pp 175–191
Eisenbrand G, Tang W, Zelezny O (1983) N-(N′-(2-Chloräthyl)-N′-nitroso-carbamoyl)-oligopeptidester und-amide und Verfahren zu ihrer Herstellung. EP 0 074 103 A1 (Int. Cl. C 07 C103/52)
Fujimoto S, Ogawa M (1982) A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(β-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity. Cancer Chemother Pharmacol 9:134–139
Johnston TP, McCaleb GS, Montgomery JA (1975) Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocin. J Med Chem 18:104–106
Mori KJ, Jasmin C, Hayat M, MacDonald JS, Mathé G (1980) In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin, (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea. Cancer Res 40:4282–4286
Ogawa M (1981) Current status of nitrosoureas under development in Japan. In: Prestayko AW et al. (eds) Nitrosoureas. Current status and new developments Acad Press, New York, pp 399–409
Schein PS, McMenamin M, Anderson T (1973) 3-(Tetra-acetylglucopyranose-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity. Cancer Res 33:2005–2009
Suami T, Kato T, Takino H, Hisamatsu T (1982) 2-Chloroethyl-nitrosourea congeners of amino acid amides. J Med Chem 25:829–832
Tang W, Eisenbrand G (1981) Synthesis of potentially antineoplastic derivatives of N-[N-(2-chloroethyl)-N-nitrosocarbamoyl] amino acids. Arch Pharm 314:910–917
Zeller WJ, Eisenbrand G, Fiebig HH (1979) Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L5222. J Cancer Res Clin Oncol 95:43–49
Zeller WJ, Berger M, Eisenbrand G, Tang W, Schmähl D (1982) Chemotherapeutic activity of 2-chloroethylnitrosocarbamoyl derivatives of amino acids in a transplanted rat leukemia (L5222). Arzneimittelforsch 32:484–486
Zeller WJ, Ehresmann K, Eisenbrand G (1984a) Antineoplastic activity of estrs and amides of N-[N′-(2-Chloroethyl)-N′-nitrosocarbamoyl]-aminoacids. J Cancer Res Clin Oncol 108:249–251
Zeller WJ, Schreiber J, Ho AD, Schmähl D, Eisenbrand G (1984b) Cytostatic activity of steroid linked nitrosoureas. J Cancer Res Clin Oncol 108:164–168
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dietrich Schmähl on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Zeller, W.J. New derivatives of CNC-amino acids and -oligopeptides: Experimental antitumor activity. J Cancer Res Clin Oncol 111, 154–156 (1986). https://doi.org/10.1007/BF00400755
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00400755